Cargando…

Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis

David Dowdy and colleagues discuss the complexities of costing new TB diagnostic tests, including GeneXpert, and argue that flexible analytic tools are needed for decision-makers to adapt large-sample cost-effectiveness data to local conditions.

Detalles Bibliográficos
Autores principales:	Dowdy, David W., Cattamanchi, Adithya, Steingart, Karen R., Pai, Madhukar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Essay
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144197/ https://www.ncbi.nlm.nih.gov/pubmed/21814496 http://dx.doi.org/10.1371/journal.pmed.1001063

Ejemplares similares

Serological tests for the diagnosis of active tuberculosis: relevance for India
por: Steingart, Karen R., et al.
Publicado: (2012)

Serological Testing Versus Other Strategies for Diagnosis of Active Tuberculosis in India: A Cost-Effectiveness Analysis
por: Dowdy, David W., et al.
Publicado: (2011)

Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults
por: Murray, Matthew, et al.
Publicado: (2016)

Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model
por: Moses, Mark W., et al.
Publicado: (2016)

Tuberculosis in times of COVID-19
por: Zimmer, Alexandra Jaye, et al.
Publicado: (2022)

An Ounce of Prevention Is Still Worth a Pound of Cure, Especially in the Time of COVID-19
por: Hacker, Karen A., et al.
Publicado: (2021)

Validating novel diagnostic assays for tuberculosis in the context of existing tools
por: Kerkhoff, Andrew D, et al.
Publicado: (2021)

Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?
por: Denkinger, Claudia M., et al.
Publicado: (2014)

Reply to Parker: Implications of Tuberculosis Sputum Culture Test Sensitivity on Accuracy of Other Diagnostic Modalities
por: Yoon, Christina, et al.
Publicado: (2019)

Innovations in Tuberculosis Diagnostics: Progress and Translational Challenges
por: Pai, Madhukar
Publicado: (2015)

Scaling Up mHealth: Where Is the Evidence?
por: Tomlinson, Mark, et al.
Publicado: (2013)

Scaling Up Evidence-Based Public Health Training
por: Brownson, Carol A., et al.
Publicado: (2018)

India is well placed to scale innovations in tuberculosis diagnostics
por: Pai, Madhukar, et al.
Publicado: (2023)

The organizational challenges in the management of the revised national tuberculosis control program of India: an overview
por: Yadav, Sankalp, et al.
Publicado: (2020)

Scaling Up Global Health Interventions: A Proposed Framework for Success
por: Yamey, Gavin
Publicado: (2011)

Making cough count in tuberculosis care
por: Zimmer, Alexandra J., et al.
Publicado: (2022)

Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective
por: Nalugwa, Talemwa, et al.
Publicado: (2020)

Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB/RIF scale-up
por: Farr, Katherine, et al.
Publicado: (2019)

Use of Rapid, Point-of-Care Assays by Private Practitioners in Chennai, India: Priorities for Tuberculosis Diagnostic Testing
por: Bronner Murrison, Liza, et al.
Publicado: (2016)

Covid-19, single-sourced diagnostic tests, and innovation policy
por: Deb, Chaarushena, et al.
Publicado: (2020)

Variation in the observed effect of Xpert MTB/RIF testing for tuberculosis on mortality: A systematic review and analysis of trial design considerations
por: Ochodo, Eleanor A., et al.
Publicado: (2020)

GeneXpert Technology for the diagnosis of HIV-associated tuberculosis: Is scale-up worth it?
por: Saeed, Muhammad, et al.
Publicado: (2020)

Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints
por: Mikkelsen, Evelinn, et al.
Publicado: (2017)

The Importance of Implementation Strategy in Scaling Up Xpert MTB/RIF for Diagnosis of Tuberculosis in the Indian Health-Care System: A Transmission Model
por: Salje, Henrik, et al.
Publicado: (2014)

Commercial Serological Antibody Detection Tests for the Diagnosis of Pulmonary Tuberculosis: A Systematic Review
por: Steingart, Karen R, et al.
Publicado: (2007)

Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model
por: Sohn, Hojoon, et al.
Publicado: (2019)

Commercial Serological Tests for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis: An Updated Systematic Review and Meta-Analysis
por: Steingart, Karen R., et al.
Publicado: (2011)

Correction: Commercial Serological Antibody Detection Tests for the Diagnosis of Pulmonary Tuberculosis: A Systematic Review
por: Steingart, Karen R, et al.
Publicado: (2007)

The Evolving Landscape of the Economics of HIV Treatment and Prevention
por: Nosyk, Bohdan, et al.
Publicado: (2012)

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2014)

Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2020)

Privacy regulations and economic efficiency: a dynamic perspective
por: Dilme, Francesc
Publicado: (2023)

Population-Level Impact of Same-Day Microscopy and Xpert MTB/RIF for Tuberculosis Diagnosis in Africa
por: Dowdy, David W., et al.
Publicado: (2013)

Using Evidence-based Community and Behavioral Interventions to Prevent Skin Cancer: Opportunities and Challenges for Public Health Practice
por: Glanz, Karen, et al.
Publicado: (2005)

How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India
por: Azman, Andrew S, et al.
Publicado: (2014)

The Sustainable Development Goals: Contextualizing Africa's Economic and Health Landscape
por: Cerf, Marlon E.
Publicado: (2018)

Behavioral Economics and Tobacco Control: Current Practices and Future Opportunities
por: Littman, Dalia, et al.
Publicado: (2022)

The American Science Pipeline: Sustaining Innovation in a Time of Economic Crisis
por: Hue, Gillian, et al.
Publicado: (2010)

Diagnostic accuracy of TB-LAMP for pulmonary tuberculosis: a systematic review and meta-analysis
por: Shete, Priya B., et al.
Publicado: (2019)

Ethics, Economics, and the Use of Primaquine to Reduce Falciparum Malaria Transmission in Asymptomatic Populations
por: Lubell, Yoel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e2vlqe09nhplhuj1e9e6dt72fo